Molecular imprint of lung cancer development

Sam Janes (London, United Kingdom)

Source: ERS Lung Science Conference 2017

Number: 2

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sam Janes (London, United Kingdom). Molecular imprint of lung cancer development. ERS Lung Science Conference 2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Molecular abnormalities and histopathology in lung cancer Source: ERS Research Seminar Year: 2015
Molecular biomarkers for lung adenocarcinoma Source: Eur Respir J , 49 (4) 1601734; DOI: 10.1183/13993003.01734-2016 Year: 2017
Molecular biologic characterization of operated non-small cell lung cancer according to smoking history Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients Year: 2008
Significance of expression of TGF-β in pulmonary metastasis in non-small cell lung cancer tissues Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Molecular pathology and precision medicine for lung cancer Source: International Congress 2017 – Precision medicine approaches in lung cancer Year: 2017
Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015
Molecular markers in non-small cell lung carcinoma Source: Eur Respir J 2006; 28: Suppl. 50, 86s Year: 2006
Cytological diagnostics of lung cancer: our experience Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005
Role of biomarkers for early detection of lung cancer and chemoprevention Source: Eur Respir J 2002; 19: 1151-1158 Year: 2002
Epigenetics and lung cancer Source: Annual Congress 2006 - Epigenetics and respiratory disease Year: 2006
Pathology and molecular biology of lung cancer Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer Year: 2006
Evolution in the pathological study of lung cancer Source: Virtual Congress 2020 – Management issues in thoracic oncology Year: 2020
The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP) Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy Year: 2013
Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013
Roles of polarized neutrophils on lung tumour development in an orthotopic lung tumour mouse model Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013
Aromatase inhibition alters the mechanical properties of non small-cell lung cancer cells affecting cell movement Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013
Early detection of lung cancer Source: Annual Congress 2013 –Biological signatures in thoracic oncology Year: 2013